DK113389A - Monoklonale antistoffer - Google Patents

Monoklonale antistoffer

Info

Publication number
DK113389A
DK113389A DK113389A DK113389A DK113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A DK 113389 A DK113389 A DK 113389A
Authority
DK
Denmark
Prior art keywords
antibodies
fragments
monoclonal antibodies
cell surface
human cell
Prior art date
Application number
DK113389A
Other languages
Danish (da)
English (en)
Other versions
DK113389D0 (da
Inventor
Manfred Brockhaus
Hansruedi Loetscher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK113389D0 publication Critical patent/DK113389D0/da
Publication of DK113389A publication Critical patent/DK113389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK113389A 1988-03-17 1989-03-08 Monoklonale antistoffer DK113389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806339A GB8806339D0 (en) 1988-03-17 1988-03-17 Monoclonal antibodies

Publications (2)

Publication Number Publication Date
DK113389D0 DK113389D0 (da) 1989-03-08
DK113389A true DK113389A (da) 1989-09-18

Family

ID=10633598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113389A DK113389A (da) 1988-03-17 1989-03-08 Monoklonale antistoffer

Country Status (10)

Country Link
EP (1) EP0334165B1 (fr)
JP (1) JPH02154695A (fr)
AT (1) ATE132197T1 (fr)
AU (1) AU618326B2 (fr)
DE (1) DE68925226T2 (fr)
DK (1) DK113389A (fr)
GB (1) GB8806339D0 (fr)
IE (1) IE890853L (fr)
NZ (1) NZ228296A (fr)
ZA (1) ZA891861B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5359037A (en) * 1988-09-12 1994-10-25 Yeda Research And Development Co. Ltd. Antibodies to TNF binding protein I
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
DK0393438T3 (da) * 1989-04-21 2005-05-30 Amgen Inc TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
ES2072330T5 (es) * 1989-05-18 2013-06-24 Yeda Research And Development Co., Ltd. Proteínas de unión II al Factor de Necrosis Tumoral, su purificación y anticuerpos frente a los mismos
US6232446B1 (en) * 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
JP3443119B2 (ja) 1989-08-07 2003-09-02 ペプテック リミテッド 腫瘍壊死因子結合リガンド
US20030225254A1 (en) 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
DK0491878T3 (da) * 1989-08-16 1997-06-23 Chiron Corp Præparater til inhibering af proteinhormondannelse og anvendelser deraf
CA2485553A1 (fr) * 1989-09-05 1991-03-21 Immunex Corporation Recepteurs .alpha. et .beta. de facteur de necrose tumorale
NZ235148A (en) * 1989-09-05 1991-12-23 Immunex Corp Tumour necrosis factor receptor protein and dna sequences
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE59010908D1 (de) * 1989-09-12 2000-08-10 Hoffmann La Roche TNF-bindende Proteine
DE4006269A1 (de) * 1990-02-28 1991-08-29 Max Planck Gesellschaft Antikoerper gegen den tumor-nekrosefaktor-rezeptor
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5582998A (en) * 1991-06-19 1996-12-10 Boehringer Ingelheim International Gmbh Monoclonal antibodies against human TNF-binding protein I (TNF-BP I) and immunoassays therefor
EP0589982B1 (fr) * 1991-06-19 2001-01-17 Boehringer Ingelheim International GmbH Anticorps monoclonaux contre la proteine i de liaison du facteur de necrose tumorale humain (p i de liaison du tnf)
ES2121907T3 (es) * 1992-08-28 1998-12-16 Bayer Ag Uso de anticuerpos monoclonales anti-tnf para el tratamiento de meningitis bacterianas.
IT1270943B (it) * 1993-05-14 1997-05-26 Mini Ricerca Scient Tecnolog Anticorpi monoclonali anti-recettore di tipo i tnf alfa, procedimento per la produzione e loro usi
EP0791360A3 (fr) * 1996-02-29 1997-09-24 Bayer Corporation Traitement du choc septique avec des anticorps anti-TNF
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
DK0942740T3 (da) 1996-12-06 2003-12-15 Amgen Inc Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
CA3004830A1 (fr) 2015-11-11 2017-05-18 Opi Vi- Ip Holdco Llc Composition et methodes pour anticorps anti-tnfr2

Also Published As

Publication number Publication date
ZA891861B (en) 1989-11-29
DK113389D0 (da) 1989-03-08
EP0334165A2 (fr) 1989-09-27
AU3125289A (en) 1989-09-21
AU618326B2 (en) 1991-12-19
GB8806339D0 (en) 1988-04-13
NZ228296A (en) 1992-01-29
EP0334165A3 (en) 1990-05-16
JPH02154695A (ja) 1990-06-14
IE890853L (en) 1989-09-17
EP0334165B1 (fr) 1995-12-27
DE68925226D1 (de) 1996-02-08
DE68925226T2 (de) 1996-05-15
ATE132197T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
DE68925226D1 (de) Monoklonale Antikörper
FI973120A0 (fi) Ihmisen gp39:n eri epitoopeille spesifisiä monoklonaalisia vasta-aineita ja menetelmiä niiden käyttämiseksi diagnosoinnissa ja terapiassa
IE861543L (en) IgE-BF
DE69429092D1 (de) Verfahren zur kontrolle von b-zellenpopulation
DE69636760D1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
FI963101A7 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoo n, joissa seerumin interleukiini-6-taso on kohonnut
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
ATE169640T1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
FI873553A7 (fi) HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä
EP0350690A3 (fr) Neutralisation des propriétés toxiques in vitro et in vivo du TNF-alfa par anticorps monoclonaux et fragments dérivés
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
EP0209543A4 (fr) Fragments de peptides d'apolipoproteines humaines, anticorps specifiques du type et procedes d'utilisation.
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DK403384D0 (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
EP0369816A3 (fr) Anticorps monoclonaux spécifiques pour la mucine polymorphe épithéliale humaine
SE9002212D0 (sv) Igg binding protein
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
EP0780472A3 (fr) Protéines de stress
KR910006478A (ko) 인체 트립타제 유사 단백질
IT8848642A0 (it) Metodo diagnostico basato sull'impiego di anticorpi ed antigeni speficatamente adatti a rivelare i processi di denaturazione proteica ela conseguente reazione autoimmunitaria che stanno alla base di alcune malattie autoimmunitarie
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment